Fortis Healthcare Ltd (FORTIS) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- Fortis Healthcare demonstrated a robust growth momentum in Q2 FY26, with both the hospital and diagnostics segments performing well in terms of revenue and margins.
- The company reported strong consolidated revenue growth of 17.3% year-on-year, primarily driven by a significant 19.3% increase in the hospital business, which now constitutes 85% of total revenue.
- Profitability saw a substantial improvement, with consolidated operating EBITDA margins expanding by 200 basis points to 23.9%, reflecting enhanced operational efficiency and a better specialty mix in the hospital segment.
- Strategic expansion initiatives gained significant traction, marked by the addition of 550 operational beds in H1 FY26 through acquisitions like Sriman Hospital in Jalandhar and new lease/O&M agreements in Greater Noida and Lucknow.
- The company maintained a healthy balance sheet with a net debt to EBITDA ratio of 0.96x, even after funding key acquisitions, positioning it well to capitalize on future growth opportunities.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.